Notice NOT-OD-22-066 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-042 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-22-155 from the NIH Guide for Grants and Contracts. Reissue of RFA-MH-20-555. The NIMH Instrumentation Program encourages applications from NIH funded investigators to purchase or upgrade a single commercially available instrument or a group of components to create an instrument that is not commercially available. Examples of instruments that might be submitted under this Funding Opportunity Announcement (FOA) include light microscopes, electron microscopes, spectrophotometers, and biomedical imagers.

Notice NOT-AR-22-016 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-041 from the NIH Guide for Grants and Contracts

Notice NOT-AG-22-012 from the NIH Guide for Grants and Contracts

Notice NOT-AG-22-011 from the NIH Guide for Grants and Contracts

Designs statistical sampling plans, performs data analysis and utilizes statistical tools to review various Quality data.
From General Electric - Sat, 22 Jan 2022 04:42:15 GMT - View all Wisconsin jobs

commensurate with experience (starts at NIH scale): Cincinnati Children's Hospital Medical Center (CCHMC): Fukun Guo, PhD, has an immediate opening in his lab for a postdoctoral Research Fellow in the Division of Experimental Hematology and Cancer Biolog... Cincinnati, Ohio

Notice NOT-OD-22-060 from the NIH Guide for Grants and Contracts

Notice NOT-OH-22-003 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-033 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-039 from the NIH Guide for Grants and Contracts

Notice NOT-GM-22-017 from the NIH Guide for Grants and Contracts

Notice NOT-GM-22-026 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-058 from the NIH Guide for Grants and Contracts. NCATS is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS. Please see Determination that a Public Health Emergency Exists Nationwide as the Result of the Opioid Crisis as renewed in Renewal of the Determination that a Public Health Emergency Exists Nationwide as the Result of the Continued Consequences of the Opioid Crisis.This Funding Opportunity Announcement (FOA) invites applications from early and mid-career investigators (i.e. postdoctoral fellow/associates associate professor) who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of therapeutic drug, biologic, or device development.

Notice NOT-HL-23-003 from the NIH Guide for Grants and Contracts

Notice NOT-DA-23-001 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-099 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology in the context of a testable cancer research hypothesis. The projects supported by this FOA will collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program. The Cancer TEC Program will (1) catalyze the advancement of innovative, well characterized in vitro and ex vivo systems available for cancer research, (2) expand the breadth of these systems to several cancer types, and (3) promote the exploration of cancer phenomena with biomimetic tissue-engineered systems.

Funding Opportunity PAR-22-084 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote epidemiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States.